Regulus Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Regulus Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Regulus Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.18M, a 33% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.18M -$582K -33% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.33M -$572K -30.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.48M -$562K -27.6% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $1.62M -$553K -25.4% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.76M -$543K -23.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $1.9M -$534K -21.9% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.04M -$525K -20.5% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.17M -$516K -19.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $2.31M -$508K -18.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.44M -$533K -18% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $2.56M +$2.31M +913% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.69M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.81M Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $2.97M Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $253K -$211K -45.5% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $464K -$2.84M -85.9% Dec 31, 2019 10-K 2021-03-09
Q3 2019 $510K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $0 Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $3.3M Jan 1, 2019 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.